Advertisement Oracle offers cloud solution to help enhance drug safety - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Oracle offers cloud solution to help enhance drug safety

Technology firm Oracle is offering a complete cloud solution to help pharma companies improve drug safety.

The company introduced a cloud version of Oracle Health Sciences Safety Suite 8.0, targeting medicinal product manufacturers, trial sponsors, contract research organizations and health authorities.

The solution offers drug safety management, which includes case management/ reporting, business analytics/intelligence, and signal detection/management, all from a single cloud-based platform.

The platform speeds up processes and enhances accuracy while reducing costs and risk. The cloud solution accelerates deployment and avoids further on-site, hardware investment.

Oracle Health Sciences vice president and general manager Steve Rosenberg said: "In the quest for treatments that are both safe and effective, life sciences organizations seek solutions that enable them to automate and improve the accuracy of their end-to-end safety processes.

"Oracle’s 8.0 release of our safety suite delivers the power of our industry-leading safety knowledge leadership along with our cloud platform for rapid innovation adoption."

Oracle Health Sciences Safety Suite 8.0 includes the company’s safety solutions, spanning the Oracle Argus and Oracle Health Sciences Empirica applications.

In June 2015, Oracle expanded clinical safety monitoring and reporting capabilities with Oracle Argus 8.0 solutions.

The company announced the availability of Oracle Argus Standard Edition 8.0, Oracle Argus Enterprise Edition 8.0, and Oracle Argus Safety Japan 8.0.

The release of Oracle’s new pharmacovigilance platform helps safety organizations comply with new reporting regulations.